FDA Inspection 1210474 — Keystone Industries

Keystone Industries — FEI 3020583487

The FDA completed an inspection of Keystone Industries on Jul 20, 2023 in Swedesboro, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 20, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Swedesboro, NJ (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
362921 CFR 211.170(b)Reserve samples identified, representative, stored
439921 CFR 211.186(b)(7)Theoretical yield statement including percentages

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.